Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial (Q33360341)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial |
scientific article |
Statements
1 reference
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial (English)
1 reference
Larry Junck
1 reference
Michael D Prados
1 reference
John Kuhn
1 reference
Susan M Chang
1 reference
Karen L Fink
1 reference
Kenneth Hess
1 reference
Kurt A Jaeckle
1 reference
Clifford Schold
1 reference
W K Alfred Yung
1 reference
Howard Fine
1 reference
Harry Greenberg
1 reference
H Ian Robins
1 reference
1 April 2004
1 reference
1 reference
100
1 reference
1712-1716
1 reference
Identifiers
1 reference
1 reference